was applied to a flash column chromatography by eluting with
ethyl acetate to give the compound 3a as a yellow solid; yield,
78 %; mp 104-105 ℃. 1H NMR (400 MHz, CDCl3): δ 9.81 (s,
Ar-H), 8.06 (dd, 1H, 4J = 1.2 Hz, 3J = 4.6 Hz, Ar-H), 7.84 (d, 1H,
4J = 2.0 Hz, Ar-H), 7.49 (dd, 1H, 3J = 4.6 Hz, 3J = 8.2 Hz, Ar-H),
4
7.14 (d, 1H, J = 2.0 Hz, Ar-H), 6.32 (s, 1H, Ar-H), 5.98 (d, 1H,
4
3
3
1H, CHO), 8.53 (dd, 1H, J = 2.0 Hz, J = 6.0 Hz, Ar-H), 7.99
3J = 2.0, NH), 5.71 (d, 1H, J = 2.4 Hz, CH), 2.70-2.65 (m, 1H,
4
3
(dd, 1H, J = 2.0 Hz, 3J = 10.8 Hz, Ar-H), 7.49 (dd, 1H, J = 6.0
NCH), 2.08 (s, 3H, Ar-CH3), 1.12-1.04 (m, 1H, CH), 0.89-0.82
(m, 1H, CH), 0.69-0.61 (m, 1H, CH), 0.52-0.45 (m, 1H, CH).
HRMS calcd for C20H16BrCl2N5O ([M-H]-): 489.9843, found:
489.9835.
Hz, 3J = 10.8 Hz, Ar-H), 7.12 (s, 1H, Ar-H).
(3-Chloro-1-(pyridin-2-yl)-1H-pyrazol-5-yl)methanol (3b)
yellow solid; yield, 80 %; mp 70-71 ℃. 1H NMR (400 MHz,
3
CDCl3): δ 10.71 (s, 1H, CHO), 8.46 (d, J = 4.3 Hz, 1H, Ar-H),
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-8-methyl-3-propyl-2,3-dihydroquinazolin-4(1H)-one
(5f) White solid; yield, 87 %; mp 198-200 ℃. 1H NMR (400
7.92 (q, 2H, Ar-H), 7.33 (t, 1H, Ar-H), 6.97 (s, 1H, Ar-H).
4
3
4.1.4. General synthetic procedure for compounds 5a-r
MHz, CDCl3): δ 8.52 (dd, 1H, J = 1.6 Hz, J = 4.6 Hz, Ar-H),
4
3
4
8.06 (dd, 1H, J = 1.4 Hz, J = 8.2 Hz, Ar-H), 7.83 (d, 1H, J =
2-Amino-5-chloro-N, 3-dimethylbenzamide (4a) (0.099 g, 0.5
mmol) and 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-
carbaldehyde (3a) (0.143 g, 0.5 mmol) were dissolved in 20 mL
of toluene, followed by a catalytic amount of p-toluenesulfonic
acid monohydrate. The resulting mixture was refluxed for 1 h
and then evaporated. The residue was dissolved in ethyl acetate
(40 mL), and washed with saturated sodium bicarbonate solution
(2 × 20 mL). The organic layer was dried over with sodium
sulfate and evaporated to obtain the crude product, which was
further purified with flash column chromatography by eluting
with petroleum ether/ethyl acetate (2:1) to afford the compound
5a as a white solid; yield, 92 %; mp 247-249 ℃. 1H NMR (400
3
3
2.4 Hz, Ar-H), 7.48 (dd, 1H, J = 4.6 Hz, J = 8.2 Hz, Ar-H),
4
7.13 (d, 1H, J = 2.0 Hz, Ar-H), 6.26 (s, 1H, Ar-H), 5.95 (d, 1H,
3J = 2.0, NH), 5.69 (d, 1H, 3J = 2.4 Hz, CH), 4.05 (m, 1H, NCH),
2.80 (m, 1H, NCH), 2.07 (s, 3H, Ar-CH3), 1.58 (m, 2H,
3
CH2CH3), 0.91 (t, 3H, J = 7.2 Hz, CH3). HRMS calcd for
C20H18BrCl2N5O ([M+H]+): 494.0145, found: 494.0140.
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-8-methyl-3-(thiazol-2-yl)-2,3-dihydroquinazolin-
4(1H)-one (5g) White solid; yield, 80 %; mp 260-262 ℃. 1H
3
NMR (400 MHz, CDCl3): δ 8.54 (d, 1H, J = 3.6 Hz, Ar-H),
8.08 (d, 1H, 3J = 8.0 Hz, Ar-H), 7.94 (s, 1H, Ar-H), 7.49 (dd, 1H,
3J = 4.4 Hz, 3J = 8.2 Hz, Ar-H), 7.41 (d, 1H, 4J = 2.8 Hz, Ar-H),
4
3
MHz, CDCl3): δ 8.50 (dd, 1H, J = 1.4 Hz, J = 4.6 Hz, Ar-H),
3
4
3
4
7.36 (d, 1H, J = 3.6 Hz, Ar-H), 7.24 (s, 1H, Ar-H), 7.04 (d, 1H,
8.05 (dd, 1H, J = 1.6 Hz, J = 8.0 Hz, Ar-H), 7.82 (d, 1H, J =
3
3
3J = 3.6 Hz, Ar-H), 6.14 (s, 1H, NH), 6.10 (s, 1H, CH), 2.14 (s,
3H, Ar-CH3). HRMS calcd for C20H13BrCl2N6OS ([M+H]+):
534.9505, found: 534.9501.
2.4 Hz, Ar-H), 7.46 (dd, 1H, J = 4.8 Hz, J = 8.0 Hz, Ar-H),
7.14 (d, 1H, 4J = 2.4 Hz, Ar-H), 6.26 (s, 1H, Ar-H), 5.95 (d, 1H,
3J = 1.6 Hz, NH), 5.71 (d, 1H, J = 3.6 Hz, CH), 3.07 (s, 3H,
3
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-3-ethyl-8-methyl-2,3-dihydroquinazolin-4(1H)-one (5h)
White solid; yield, 65 %; mp 222-224 ℃. 1H NMR (300 MHz,
NCH3), 2.09 (s, 3H, Ar-CH3). HRMS calcd for C18H14BrCl2N5O
([M-H]-): 463.9686, found: 463.9682.
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-3-methoxy-8-methyl-2,3-dihydroquinazolin-4(1H)-one
(5b) White solid; yield, 89 %; mp 200-202 ℃. 1H NMR (400
4
3
CDCl3): δ 8.52 (dd, 1H, J = 1.7 Hz, J = 4.7 Hz, Ar-H), 8.06
(dd, 1H, 4J = 1.5 Hz, 3J = 8.1 Hz, Ar-H), 7.83 (d, 1H, 4J = 2.1 Hz,
Ar-H), 7.48 (dd, 1H, 3J = 4.8 Hz, 3J = 8.1 Hz, Ar-H), 7.13 (d, 1H,
4
3
MHz, CDCl3): δ 8.48 (dd, 1H, J = 1.6 Hz, J = 4.8 Hz, Ar-H),
3
4
3
4
4J = 2.4 Hz, Ar-H), 6.26 (s, 1H, Ar-H), 5.99 (d, 1H, J = 1.8 Hz,
8.04 (dd, 1H, J = 1.4 Hz, J = 8.2 Hz, Ar-H), 7.84 (d, 1H, J =
3
3
3
NH), 5.72 (d, 1H, J = 2.4 Hz, CH), 4.12-4.00 (m, 1H, NCH),
2.4 Hz, Ar-H), 7.45 (dd, 1H, J = 4.8 Hz, J = 8.0 Hz, Ar-H),
3
4
3.07-2.95 (m, 1H, NCH), 2.08 (s, 3H, Ar-CH3), 1.18 (t, 3H, J =
7.18 (d, 1H, J = 2.0 Hz, Ar-H), 6.44 (s, 1H, Ar-H), 6.07 (br s,
7.2 Hz, CH3). HRMS calcd for C19H16BrCl2N5O ([M+Na]+):
501.9813, found: 501.9800.
1H, NH), 6.03 (d, 1H, 3J = 2.4, CH), 3.83 (s, 3H, OCH3), 2.11 (s,
3H, Ar-CH3). HRMS calcd for C18H14BrCl2N5O2 ([M+H]+):
481.9781, found: 481.9785.
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-3-
methyl-2,3-dihydroquinazolin-4(1H)-one (5i) White solid;
yield, 70 %; mp 233-235 ℃. 1H NMR (400 MHz, CDCl3): δ
8.52 (dd, 1H, 4J = 1.6 Hz, 3J = 4.4 Hz, Ar-H), 8.04 (dd, 1H, 4J =
1.2 Hz, 3J = 8.0 Hz, Ar-H), 7.98 (d, 1H, 3J = 7.6 Hz, Ar-H), 7.46
(dd, 1H, 3J = 4.8 Hz, 3J = 8.0 Hz, Ar-H), 7.30 (t, 1H, 3J = 8.0 Hz,
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-3-isopropyl-8-methyl-2,3-dihydroquinazolin-4(1H)-
one (5c) White solid; yield, 88 %; mp 222-224 ℃. 1H NMR
4
3
(400 MHz, CDCl3): δ 8.55 (dd, 1H, J = 1.4 Hz, J = 4.6 Hz,
Ar-H), 8.08 (dd, 1H, 4J = 1.6 Hz, 3J = 8.2 Hz, Ar-H), 7.84 (d, 1H,
4J = 2.4 Hz, Ar-H), 7.51 (dd, 1H, 3J = 4.4 Hz, 3J = 8.0 Hz, Ar-H),
3
3
Ar-H), 6.90 (t, 1H, J = 7.6 Hz, Ar-H), 6.62 (d, 1H, J = 7.6 Hz,
3
4
Ar-H), 6.28 (s, 1H, Ar-H), 5.74 (s, 1H, NH), 5.64 (d, 1H, J =
7.13 (d, 1H, J = 2.0 Hz, Ar-H), 6.27 (s, 1H, Ar-H), 5.88 (d, 1H,
3J = 2.0, NH), 5.67 (d, 1H, 3J = 2.4 Hz, CH), 4.97 (m, 1H, NCH),
2.09 (s, 3H, Ar-CH3), 1.18 (d, 3H, 3J = 6.8 Hz, CH3), 1.01 (d, 3H,
3J = 6.8 Hz, CH3). HRMS calcd for C20H18BrCl2N5O ([M+H]+):
494.0145, found: 494.0146.
2.0 Hz, CH), 3.05 (s, 3H, NCH3).
HRMS calcd for
C17H13BrClN5O ([M+Na]+): 439.9890, found: 439.9897.
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-3,8-
dimethyl-2,3-dihydroquinazolin-4(1H)-one (5j) White solid;
yield, 80 %; mp 265-267 ℃. 1H NMR (300 MHz, CDCl3): δ
8.51 (dd, 1H, 4J = 1.4 Hz, 3J = 4.7 Hz, Ar-H), 8.05 (dd, 1H, 4J =
1.2 Hz, 3J = 8.1 Hz, Ar-H), 7.86 (d, 1H, 3J = 7.8 Hz, Ar-H), 7.47
(dd, 1H, 3J = 4.8 Hz, 3J = 8.1 Hz, Ar-H), 7.17 (d, 1H, 3J = 7.2 Hz,
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-3-
tert-butyl-6-chloro-8-methyl-2,3-dihydroquinazolin-4(1H)-
one (5d) White solid; yield, 85 %; mp 168-170 ℃. 1H NMR
4
3
(400 MHz, CDCl3): δ 8.53 (dd, 1H, J = 1.2 Hz, J = 4.8 Hz,
Ar-H), 8.06 (dd, 1H, 4J = 1.0 Hz, 3J = 8.0 Hz, Ar-H), 7.83 (d, 1H,
4J = 1.6 Hz, Ar-H), 7.49 (dd, 1H, 3J = 4.8 Hz, 3J = 8.0 Hz, Ar-H),
3
Ar-H), 6.82 (t, 1H, J = 7.7 Hz, Ar-H), 6.28 (s, 1H, Ar-H), 5.92
3
(s, 1H, NH), 5.72 (d, 1H, J = 2.1 Hz, CH), 3.08 (s, 3H, NCH3),
3
2.11 (s, 1H, Ar-CH3). HRMS calcd for C18H15BrClN5O
7.11 (s, 1H, Ar-H), 6.32 (s, 1H, Ar-H), 6.00 (d, 1H, J = 3.2,
([M+Na]+): 454.0046, found: 454.0047.
NH), 5.74 (d, 1H, 3J = 2.0 Hz, CH), 2.06 (s, 3H, Ar-CH3), 1.47 (s,
HRMS calcd for C21H20BrCl2N5O ([M+H]+):
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-8-methyl-2,3-dihydroquinazolin-4(1H)-one (5k) White
9H, CH3).
508.0301, found: 508.0302.
1
solid; yield, 75 %; mp 222-224 ℃. H NMR (400 MHz, CDCl3):
2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-
chloro-3-cyclopropyl-8-methyl-2,3-dihydroquinazolin-4(1H)-
one (5e) White solid; yield, 91 %; mp 267-269 ℃. 1H NMR
δ 8.47 (dd, 1H, 4J = 1.0 Hz, 3J = 4.6 Hz, Ar-H), 8.03 (dd, 1H, 4J
3
4
= 1.2 Hz, J = 8.0 Hz, Ar-H), 7.79 (d, 1H, J = 2.0 Hz, Ar-H),
3
3
4
4
3
7.45 (dd, 1H, J = 4.8 Hz, J = 8.0 Hz, Ar-H), 7.20 (d, 1H, J =
(400 MHz, CDCl3): δ 8.52 (dd, 1H, J = 1.4 Hz, J = 4.6 Hz,